Treatment to enhance cognition in bipolar disorder (TREC-BD): Efficacy of a randomized controlled trial of cognitive remediation versus active control

Journal of Clinical Psychiatry

Volumn 78, Issue 9, 2017, Pages e1242-e1249

  Lewandowski, Kathryn E ^a,b   Sperry, Sarah H ^a   Cohen, Bruce M ^a,b   Norris, Lesley A ^a   Fitzmaurice, Garrett M ^a,b,c   Ongur, Dost ^a,b   Keshavan, Matcheri S ^b,d  

^a MCLEAN HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CHLORPROMAZINE; LITHIUM SALT; MOOD STABILIZER; NEUROLEPTIC AGENT;

ADULT; ARTICLE; BIPOLAR DISORDER; COGNITIVE DEFECT; COGNITIVE REMEDIATION THERAPY; COMMUNITY DYNAMICS; COMPUTER ASSISTED THERAPY; CONTROLLED STUDY; FEMALE; HUMAN; INTENTION TO TREAT ANALYSIS; LEARNING; MAJOR CLINICAL STUDY; MALE; MEMORY; NERVOUS SYSTEM PARAMETERS; OUTCOME ASSESSMENT; PARALLEL DESIGN; PRIORITY JOURNAL; PROCESSING SPEED; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SOCIAL INTERACTION; THERAPY EFFECT; TREATMENT DURATION; VISUAL LEARNING; COMPARATIVE STUDY; COMPLICATION; PROCEDURES; PSYCHOLOGY; SOCIAL ADAPTATION;

ADULT; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; COGNITIVE DYSFUNCTION; COGNITIVE REMEDIATION; FEMALE; HUMANS; MALE; SOCIAL ADJUSTMENT;

EID: 85040032449     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.17m11476     Document Type: Article

References (44)

1. Green MF. Cognitive impairment and functional outcome in schizophrenia and bipolar disorder. JClinPsychiatry. 2006;67(suppl 9):3–8, discussion 36.
2. Martino DJ, Marengo E, Igoa A, et al. Neurocognitive and symptomatic predictors of functional outcome in bipolar disorders: a prospective 1 year follow-up study. JAffect Disord. 2009;116(1–2):37–42.
3. Gruber SA, Rosso IM, Yurgelun-Todd D. Neuropsychological performance predicts clinical recovery in bipolar patients. JAffect Disord. 2008;105(1-3):253–260.
4. Huxley N, Baldessarini RJ. Disability and its treatment in bipolar disorder patients. Bipolar Disord. 2007;9(1–2):183–196.
5. Goodwin GM, Martinez-Aran A, Glahn DC, et al. Cognitive impairment in bipolar disorder: neurodevelopment or neurodegeneration? an ECNP expert meeting report. Eur Neuropsychopharmacol. 2008;18(11):787–793.
6. Arts B, Jabben N, Krabbendam L, et al. Meta-analyses of cognitive functioning in euthymic bipolar patients and their first-degree relatives. PsycholMed. 2008;38(6):771–785.
7. Glahn DC, Bearden CE, Barguil M, et al. The neurocognitive signature of psychotic bipolar disorder. BiolPsychiatry. 2007;62(8):910–916.
8. Robinson LJ, Thompson JM, Gallagher P, et al. A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J Affect Disord. 2006;93(1–3):105–115.
9. Rubinsztein JS, Michael A, Paykel ES, et al. Cognitive impairment in remission in bipolar affective disorder. PsycholMed. 2000;30(5):1025–1036.
10. Sperry SH, O’Connor LK, Öngür D, et al. Measuring cognition in bipolar disorder with psychosis using the MATRICS Consensus Cognitive Battery. JIntNeuropsycholSoc. 2015;21(6):468–472.
11. Lewandowski KE, Cohen BM, Keshavan MS, et al. Neuropsychological functioning predicts community outcomes in affective and non-affective psychoses: a 6-month follow-up. Schizophr Res. 2013;148(1-3):34–37.
12. Martinez-Aransega A, Torrent C, Tabares-Seisdedosopos R, et al. Neurocognitive impairment in bipolar patients with and without history of psychosis. J Clin Psychiatry. 2008;69(2):233–239.
13. Simonsen C, Sundet K, Vaskinn A, et al. Neurocognitive dysfunction in bipolar and schizophrenia spectrum disorders depends on history of psychosis rather than diagnostic group. Schizophr Bull. 2011;37(1):73–83.
14. Burdick KE, Russo M, Frangou S, et al. Empirical evidence for discrete neurocognitive subgroups in bipolar disorder: clinical implications. Psychol Med. 2014;44(14):3083–3096.
15. Lewandowski KE, Sperry SH, Cohen BM, et al. Cognitive variability in psychotic disorders: a cross-diagnostic cluster analysis. PsycholMed. 2014;44(15):3239–3248.
16. Wykes T, Huddy V, Cellard C, et al. A meta-analysis of cognitive remediation for schizophrenia: methodology and effect sizes. AmJPsychiatry. 2011;168(5):472–485.
17. Anaya C, Martinez Aran A, Ayuso-Mateos JL, et al. A systematic review of cognitive remediation for schizo-affective and affective disorders. J Affect Disord. 2012;142(1-3):13–21.
18. Deckersbach T, Nierenberg AA, Kessler R, et al. RESEARCH: cognitive rehabilitation for bipolar disorder: an open trial for employed patients with residual depressive symptoms. CNS NeurosciTher. 2010;16(5):298–307.
19. Demant KM, Vinberg M, Kessing LV, et al. Effects of short-term cognitive remediation on cognitive dysfunction in partially or fully remitted individuals with bipolar disorder: results of a randomised controlled trial. PLoS One. 2015;10(6):e0127955.
20. Martínez-Arán A, Torrent C, Solé B, et al. Functional remediation for bipolar disorder. Clin PractEpidemiolMentHealth. 2011;7(1):112–116.
21. Bonnin CM, Reinares M, Martínez-Arán A, et al. Effects of functional remediation on neurocognitively impaired bipolar patients: enhancement of verbal memory. PsycholMed. 2016;46(2):291–301.
22. Lewandowski KE, Sperry SH, Ongur D, et al. Cognitive remediation versus active computer control in bipolar disorder with psychosis: study protocol for a randomized controlled trial. Trials. 2016;17(1):136.
23. Foroughi CK, Monfort SS, Paczynski M, et al. Placebo effects in cognitive training. ProcNatl AcadSciUSA. 2016;113(27):7470–7474.
24. Fisher M, Holland C, Merzenich MM, et al. Using neuroplasticity-based auditory training to improve verbal memory in schizophrenia. Am J Psychiatry. 2009;166(7):805–811.
25. Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMCMed. 2010;8(1):18.
26. Vinogradov S, Fisher M, Warm H, et al. The cognitive cost of anticholinergic burden: decreased response to cognitive training in schizophrenia. Am J Psychiatry. 2009;166(9):1055–1062.
27. Nuechterlein KH, Green MF, Kern RS, et al. The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity. Am J Psychiatry. 2008;165(2):203–213.
28. Burdick KE, Goldberg TE, Cornblatt BA, et al. The MATRICS consensus cognitive battery in patients with bipolar I disorder. Neuropsychopharmacology. 2011;36(8):1587–1592.
29. Kay SR, Fiszbein A, Opler LA. The Positive and Negative Syndrome Scale (PANSS) for schizophrenia. Schizophr Bull. 1987;13(2):261–276.
30. Young RC, Biggs JT, Ziegler VE, et al. A rating scale for mania: reliability, validity and sensitivity. BrJPsychiatry. 1978;133(5):429–435.
31. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134(4):382–389.
32. Barker S, Barron N, McFarland BH, et al. A community ability scale for chronically mentally ill consumers, part II: applications. CommunityMentHealthJ. 1994;30(5):459–472.
33. Mahncke HW, Bronstone A, Merzenich MM. Brain plasticity and functional losses in the aged: scientific bases for a novel intervention. Prog Brain Res. 2006;157:81–109.
34. Cohen J. Statistical Power Analysis for the Behavioral Sciences. New York, NY: Routledge Academic; 1988
35. Torrent C, Bonnin CM, Martínez-Arán A, et al. Efficacy of functional remediation in bipolar disorder: a multicenter randomized controlled study. AmJPsychiatry. 2013;170(8):852–859.
36. de la Fuente-Fernández R, Ruth TJ, Sossi V, et al. Expectation and dopamine release: mechanism of the placebo effect in Parkinson’s disease. Science. 2001;293(5532):1164–1166.
37. Scott DJ, Stohler CS, Egnatuk CM, et al. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. ArchGen Psychiatry. 2008;65(2):220–231.
38. Tennstedt SL, Unverzagt FW. The ACTIVE study: study overview and major findings. JAging Health. 2013;25(suppl):3S–20S.
39. Bell MD, Zito W, Greig T, et al. Neurocognitive enhancement therapy with vocational services: work outcomes at two-year follow-up. Schizophr Res. 2008;105(1–3):18–29.
40. Bowie CR, McGurk SR, Mausbach B, et al. Combined cognitive remediation and functional skills training for schizophrenia: effects on cognition, functional competence, and real-world behavior. AmJPsychiatry. 2012;169(7):710–718.
41. Keefe RS, Vinogradov S, Medalia A, et al. Report from the working group conference on multisite trial design for cognitive remediation in schizophrenia. Schizophr Bull. 2011;37(5):1057–1065.
42. Corbera S, Wexler BE, Poltorak A, et al. Cognitive remediation for adults with schizophrenia: does age matter. Psychiatry Res. 2017;247:21–27.
43. Medalia A, Saperstein AM. Does cognitive remediation for schizophrenia improve functional outcomes? Curr Opin Psychiatry. 2013;26(2):151–157.
44. Ventura J, Wilson SA, Wood RC, et al. Cognitive training at home in schizophrenia is feasible. Schizophr Res. 2013;143(2–3):397–398.